The monoclonal antibody mAb 3G8 against FcγRIIIa has shown promising effect on autoimmune diseases, as mAb 3G8 is able to induce clearance of the inflammatory immune complexes by selectively blocking FcγRIIIa binding to IgG [19, 20]. This evidence concerns the gene FCGR3A and autoimmune disease.